AU2015202575B9 - Using palmitoylethanolamide in combination with opioids - Google Patents

Using palmitoylethanolamide in combination with opioids Download PDF

Info

Publication number
AU2015202575B9
AU2015202575B9 AU2015202575A AU2015202575A AU2015202575B9 AU 2015202575 B9 AU2015202575 B9 AU 2015202575B9 AU 2015202575 A AU2015202575 A AU 2015202575A AU 2015202575 A AU2015202575 A AU 2015202575A AU 2015202575 B9 AU2015202575 B9 AU 2015202575B9
Authority
AU
Australia
Prior art keywords
palmitoylethanolamide
opioid
treatment
pea
micronized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015202575A
Other languages
English (en)
Other versions
AU2015202575A1 (en
AU2015202575B2 (en
Inventor
Francesco Della Valle
Maria Federica Della Valle
Lorenzo Di Cesare Manelli
Carla Ghelardini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epitech Group SpA
Original Assignee
Epitech Group SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitech Group SpA filed Critical Epitech Group SpA
Publication of AU2015202575A1 publication Critical patent/AU2015202575A1/en
Application granted granted Critical
Publication of AU2015202575B2 publication Critical patent/AU2015202575B2/en
Publication of AU2015202575B9 publication Critical patent/AU2015202575B9/en
Assigned to EPITECH GROUP S.P.A. reassignment EPITECH GROUP S.P.A. Request to Amend Deed and Register Assignors: EPITECH GROUP S.R.L.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dispersion Chemistry (AREA)
AU2015202575A 2014-05-14 2015-05-13 Using palmitoylethanolamide in combination with opioids Active AU2015202575B9 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20140876 2014-05-14
ITMI2014A000876 2014-05-14

Publications (3)

Publication Number Publication Date
AU2015202575A1 AU2015202575A1 (en) 2015-12-03
AU2015202575B2 AU2015202575B2 (en) 2020-03-05
AU2015202575B9 true AU2015202575B9 (en) 2020-03-26

Family

ID=51179022

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015202575A Active AU2015202575B9 (en) 2014-05-14 2015-05-13 Using palmitoylethanolamide in combination with opioids

Country Status (17)

Country Link
US (1) US9801836B2 (enExample)
EP (1) EP2944309B1 (enExample)
JP (1) JP6563685B2 (enExample)
KR (1) KR102507891B1 (enExample)
CN (1) CN105079811B (enExample)
AR (1) AR100444A1 (enExample)
AU (1) AU2015202575B9 (enExample)
BR (1) BR102015011079A2 (enExample)
CA (1) CA2891049C (enExample)
CY (1) CY1121773T1 (enExample)
DK (1) DK2944309T3 (enExample)
ES (1) ES2731729T3 (enExample)
HU (1) HUE044915T2 (enExample)
PL (1) PL2944309T3 (enExample)
PT (1) PT2944309T (enExample)
SM (1) SMT201900345T1 (enExample)
TR (1) TR201908936T4 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL322263A (en) * 2015-05-21 2025-09-01 Scisparc Ltd Combinations of opioids and acetylamines
PH12018000077B1 (en) 2017-07-05 2021-07-09 Frimline Private Ltd A pharmaceutical composition for neuropathic pain
PH12018000227A1 (en) 2017-09-05 2019-03-11 Frimline Private Ltd A pharmaceutical composition for improving or preventing progression of chronic kidney disease
WO2020141546A1 (en) * 2019-01-02 2020-07-09 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for pain management

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171313A1 (en) * 2009-09-07 2011-07-14 Francesco Della Valle Composition containing ultra-micronized palmitoyl-ethanolamide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271266B (it) 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
US6548550B1 (en) 1999-08-06 2003-04-15 Innovet Italia S.R.L. Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field
ES2312643T5 (es) * 2001-07-18 2011-10-18 Unilever N.V. Composiciones para el tratamiento del cabello y/o del cuero cabelludo.
US20050245557A1 (en) * 2003-10-15 2005-11-03 Pain Therapeutics, Inc. Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain
JP2012522004A (ja) * 2009-03-27 2012-09-20 アボット・ラボラトリーズ カンナビノイド受容体リガンドである化合物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171313A1 (en) * 2009-09-07 2011-07-14 Francesco Della Valle Composition containing ultra-micronized palmitoyl-ethanolamide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GATTI A ET AL, PAIN MEDICINE, 2012, vol. 13, no. 9, pages 112-1130 *
STEPHEN D. SKAPER ET AL, INFLAMMOPHARMACOLOGY, (2013-11-01), vol. 22, no. 2, pages 79-94 *

Also Published As

Publication number Publication date
KR102507891B1 (ko) 2023-03-08
AR100444A1 (es) 2016-10-05
KR20150130931A (ko) 2015-11-24
CA2891049C (en) 2023-02-21
CA2891049A1 (en) 2015-11-14
DK2944309T3 (da) 2019-06-03
BR102015011079A2 (pt) 2016-03-29
PL2944309T3 (pl) 2019-09-30
CN105079811B (zh) 2020-06-23
CN105079811A (zh) 2015-11-25
PT2944309T (pt) 2019-06-05
AU2015202575A1 (en) 2015-12-03
JP6563685B2 (ja) 2019-08-21
US20150328173A1 (en) 2015-11-19
HUE044915T2 (hu) 2019-11-28
SMT201900345T1 (it) 2019-07-11
US9801836B2 (en) 2017-10-31
TR201908936T4 (tr) 2019-07-22
AU2015202575B2 (en) 2020-03-05
CY1121773T1 (el) 2020-07-31
ES2731729T3 (es) 2019-11-18
EP2944309A1 (en) 2015-11-18
JP2015221794A (ja) 2015-12-10
EP2944309B1 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
JP6216305B2 (ja) 薬物過量摂取の治療のためのモルヒナン誘導体
US5256669A (en) Methods and compositions for treating acute or chronic pain and drug addiction
WO2007005716A2 (en) Methods of treatment and compositions for use thereof
AU2015202575B9 (en) Using palmitoylethanolamide in combination with opioids
WO2019241005A1 (en) Compositions and methods for treating respiratory depression with fenfluramine
WO2008107410A1 (en) Analgesic composition of topically applied nonsteroidal antiinflammatory drugs and opioids
JP2014515405A (ja) オピオイド受容体アゴニストの逐次投与のための組成物
JPH05132430A (ja) 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法
JP2014505113A (ja) 末梢作用性μオピオイドアンタゴニスト
KR20090125748A (ko) 대상포진 후 신경통 치료용 정제 및 대상포진 후 신경통의 치료 방법
WO2005107467A2 (en) Compositions including opioids and methods of their use in treating pain
CA3073186C (en) Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate
EP2694050A1 (en) Tapentadol for treating pain associated with trigeminal neuralgia
EP3590511A1 (en) Therapeutic agent for alcohol use disorders
HK1223246A1 (zh) 疼痛药物组合及其用途
JP2009502828A (ja) Ｎｍｄａ受容体遮断薬と麻薬性鎮痛物質とを含む治療用組合せ
JPWO1997006139A1 (ja) 麻薬性鎮痛剤の依存・耐性形成抑制剤

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: EPITECH GROUP S.P.A.

Free format text: FORMER NAME(S): EPITECH GROUP S.R.L.